Pharmafile Logo

Webinar: Understanding the Patient Journey in China 2015

January 6, 2016 | Chinese Healthcare, Patient journey 

Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.

As the affluent middle-class continues to grow and healthcare reforms look set to affect the way that patients access treatment, the Chinese healthcare market is experiencing a period of great change. 

Most recently there are concerns that the devaluation in China’s currency has impacted significantly on the local healthcare demand and that the much publicised healthcare reforms that were due to take effect this year have stalled in the implementation. 

Now more than ever, the researcher needs to ensure that they have a full understanding of how these developments will impact the market.

Register now for the latest in our China webinar series where, utilising local knowledge and detailed case studies, we will examine the current Chinese healthcare market, discuss the likely impact of the Government’s healthcare reforms on the patient journey and consider the possible implication for market researchers.

Our Emerging Markets experts Marc Yates and Rachel Howard will also be considering the impact of China’s more recent financial challenges including the lack of growth within the private sector.

Gain answers to your key questions:

  • Gain a deeper understanding of the changing patient journey in China
  • Identify the opportunities and challenges associated with the healthcare reforms 
  • Learn how to ensure that your market research in China continues to answer the business objectives

To view the webinar please visit: bit.ly/1O05iUJ

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Video: Immuno-oncology therapies

Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high...

Event: EULAR Annual European Congress of Rheumatology 2016

We are delighted to be attending the EULAR Annual European Congress of Rheumatology in June. Representing Research Partnership is Business Development Manager, Fara Mboge. He will be on hand to...

Forever Angels achievements and development plan for 2016

Research Partnership is proud to support Forever Angels in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania

The Opportunity for Women’s Health in Emerging Markets

Published in eyeforpharma April 2016 by Rachel Howard

Video: Storytelling in healthcare market research

Within the pharmaceutical industry, there is an increasing need for market research teams to share the insights with their key internal stakeholders, from marketing and brand managers to sales reps...

Promotions and new appointments across our global offices

Research Partnership is delighted to announce promotions and new starters in the UK and further appointments in the US and Singapore offices

Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?

In a past Free Thinking paper, we looked at the opportunity and challenges for biosimilar mAbs entering the rheumatoid arthritis market. A few years later and according to our Therapy...

Webcast: Understanding the Chronic Disease Patient Journey in Emerging Markets

In emerging markets where primary care systems do not exist, the patient is the only constant in the journey

Living with Crohn’s Report

Are you looking for a deeper understanding of the emotional needs, behaviours and treatment programmes of patients living with Crohn’s Disease?

Infographic: Research Partnership

Our latest infographic offers an overview of some key facts and figures about the company, its services and capabilities.